Want to see MWAI full AI Analyst Report?
MWAI Stock Chart & Stats
$0.35
$0.00(0.00%)
At close: 4:00 PM EDT
$0.35
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.18 - $0.76
Previous CloseN/A
Volume3.92K
Average Volume (3M)1.80K
Market Cap
$1.95M
Enterprise Value$2.07T
Total Cash (Recent Filing)$86.22K
Total Debt (Recent Filing)$500.00K
Price to Earnings (P/E)―
Beta0.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding6,536,580
10 Day Avg. Volume4,252
30 Day Avg. Volume1,803
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.23
Price to Sales (P/S)3.43
P/FCF Ratio-5.75
Enterprise Value/Market Cap1.06M
Enterprise Value/Revenue3.92M
Enterprise Value/Gross Profit5.92M
Enterprise Value/Ebitda-1.78M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AI Healthcare FocusMedWellAI is positioned in the digital-health and AI software sectors, applying artificial intelligence to medical and wellness workflows. This gives the company exposure to technology adoption in healthcare and a model that can potentially scale through software-based tools and services.
High Gross MarginGross margins of 94–99% indicate that the company’s reported offerings have limited direct costs relative to revenue. If revenue can recover and operating expenses become better aligned with the business scale, this margin structure could support improved operating leverage over time.
Improving Net Margin TrendThe substantial improvement in net margin from FY2025 to FY2026 shows some progress in earnings performance, even though the company remains deeply unprofitable. Continued improvement could reduce the distance to breakeven if revenue stabilizes and expenses remain controlled.
Bears Say
Severe Revenue ContractionA 63.2% annual revenue decline and highly volatile sales materially weaken the company’s operating base. Lower revenue reduces the ability to absorb fixed costs, makes profitability harder to reach, and raises uncertainty about whether the current business model can produce dependable growth.
Persistent UnprofitabilityLarge operating losses and persistently negative net margins show that the business has not yet translated its high gross margin into sustainable earnings. Continued losses can consume available resources, limit internally funded investment, and keep the company dependent on future improvement or financing.
Weak Solvency And Cash GenerationNegative operating and free cash flow, combined with approximately $8.0 million of negative shareholders’ equity in FY2026, indicates limited financial flexibility. If cash burn persists, the company may need external funding or balance-sheet actions, potentially on less favorable terms.
MedWellAI News
MWAI FAQ
What was MedWellAI’s price range in the past 12 months?
MedWellAI lowest stock price was $0.18 and its highest was $0.76 in the past 12 months.
What is MedWellAI’s market cap?
MedWellAI’s market cap is $1.95M.
When is MedWellAI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MedWellAI’s earnings last quarter?
MedWellAI released its earnings results on Nov 18, 2025. The company reported -$0.105 earnings per share for the quarter.
Is MedWellAI overvalued?
According to Wall Street analysts MedWellAI’s price is currently Overvalued.
Does MedWellAI pay dividends?
MedWellAI does not currently pay dividends.
What is MedWellAI’s EPS estimate?
MedWellAI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedWellAI have?
MedWellAI has 6,536,580 shares outstanding.
What happened to MedWellAI’s price movement after its last earnings report?
MedWellAI reported an EPS of -$0.105 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MedWellAI?
Currently, no hedge funds are holding shares in MWAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedWellAI
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.
Technical Analysis
―
Xiao-I Corp. ADR
―
Simpple Ltd.
―
Health In Tech, Inc. Class A
―
Cloudastructure, Inc. Class A
―

